General Information
Age Group
AdultsStatus
RecruitingProtocol Number
BK-JM-201
Background Information
Research Question: To compare the efficacy of the study medication to that of placebo therapy in reducing dyskinesia severity in Parkinson's disease.
Offered At
Inova Medical Group – Neurology
8081 Innovation Park Dr., #900
Fairfax, VA 22031
Eligibility Information
- Adults, between 18 and 80 years of age at screening visit
- Is diagnosed with idiopathic PD that meets UK Parkinson's Disease Society (UKPDS) Brain Bank Clinical Diagnostic Criteria
- Has experienced dyskinesia
- Has stable peak-effect dyskinesia
- Has more than one hour of "ON" time with troublesome dyskinesia
Ineligibility Information
- Has undergone surgery for the treatment of PD
- Has a current diagnosis of substance use
- Has psychiatric diagnosis of acute psychotic disorder or other psychiatric diagnoses
- Has current seizure disorders requiring treatment with anticonvulsants.
Additional information can be found at: https://clinicaltrials.gov/ct2/show/NCT04377945?term=BK-JM-201&draw=2&rank=1